Pharmacovigilance Services in Dominican Republic

Pharmacovigilance in Dominican Republic covers the safety work that continues long after a product receives market approval — tracking how a medicine performs in everyday use, catching adverse events, following up on emerging risks, and confirming that its benefit-risk balance holds up over time. Oversight falls under the Ministerio de Salud Pública, and organisations placing products on the Dominican market are expected to run a functioning safety system, not just meet reporting deadlines.

This responsibility applies broadly — to pharmaceutical manufacturers, biotechnology companies, Marketing Authorisation Holders, importers, and distributors alike — and it doesn't end once a product clears its first year on the market. It continues for as long as the product is sold, adjusting as new safety data comes in from real-world use.

DDReg provides pharmacovigilance services in Dominican Republic covering the full scope of this work: adverse event and case management, signal detection, aggregate safety reporting , literature monitoring, and local safety contact support — built to satisfy Dominican regulatory requirements while staying consistent with an organization's broader global safety operations.

DDReg supports organisations across the life sciences sector, including:

• Pharmaceutical manufacturers
• Biotechnology companies
• Generic medicine manufacturers
• Biologics and biosimilar companies
• Vaccine manufacturers
• Marketing Authorisation Holders (MAHs)
• Importers and distributors
• Contract Research Organisations (CROs)
• Healthcare organisations expanding into the Dominican Republic

Our pharmacovigilance services are designed to support both local operations and multinational product portfolios, allowing organisations to manage country-specific obligations while maintaining alignment with global pharmacovigilance systems.

Every organisation has different pharmacovigilance requirements depending on its products, markets, and internal capabilities. DDReg offers flexible pharmacovigilance solutions that can strengthen existing safety systems or provide complete outsourcing support, helping organisations maintain compliance while improving operational efficiency.

• Pharmacovigilance Strategy and System Development

  We work with organisations to review pharmacovigilance governance, reporting procedures, quality systems, and operational responsibilities before developing practical solutions that support long-term compliance. Through our Dominican Republic pharmacovigilance consulting services, we help organisations establish efficient programmes aligned with local expectations and international standards.

• Adverse Event Management and ICSR Processing

  Our team manages every stage of Individual Case Safety Report (ICSR) processing, including adverse event intake, medical assessment, MedDRA coding, quality review, follow-up activities, narrative writing, database management, and regulatory submissions.

• Aggregate Safety Reporting and Benefit-Risk Assessment

  Depending on organisational requirements, we provide support for aggregate safety reports, medical review, safety trend evaluation, and benefit-risk assessments to support informed regulatory decisions and ongoing compliance.

• Signal Detection and Literature Surveillance

  Continuous monitoring of safety information is fundamental to an effective pharmacovigilance programme. DDReg reviews adverse event reports, scientific publications, and other relevant safety information to identify potential safety signals and support proactive risk management.

• Pharmacovigilance Documentation and Quality Management

  We prepare and maintain inspection-ready documentation, including Standard Operating Procedures (SOPs), pharmacovigilance agreements, quality management documentation, CAPA records, compliance documentation, and audit support materials.

• Local Pharmacovigilance Support

  As a trusted Local Pharmacovigilance Provider in Dominican Republic, DDReg supports local regulatory communication, safety coordination, country-specific reporting requirements, and integration with global pharmacovigilance operations.

• Drug Safety Services and PV Outsourcing

  Our Drug Safety Services in Dominican Republic cover post-marketing surveillance, safety reporting, benefit-risk evaluation, and ongoing pharmacovigilance management. Through our PV Outsourcing Services in Dominican Republic, organisations can outsource selected pharmacovigilance functions or implement fully managed pharmacovigilance programmes tailored to their operational needs.